Hawkhill Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.71M

  • Investors
  • 6

Hawkhill Therapeutics General Information

Description

Developer of a first-in-class oral therapy designed for obesity and metabolic health. The company's technology utilizes small-molecule discovery and muscle-sparing mechanisms to enable fat reduction, muscle mass preservation, and improved tolerability, providing patients with obesity an oral alternative to current metabolic drugs intended to improve overall health and longevity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Life Sciences Innovation Hub
  • 5 James Lindsay Place
  • Dundee DD1 5JJ
  • Scotland, United Kingdom
+44 055
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Life Sciences Innovation Hub
  • 5 James Lindsay Place
  • Dundee DD1 5JJ
  • Scotland, United Kingdom
+44 055

Hawkhill Therapeutics Timeline

2026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hawkhill Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 28-Sep-2026 $3.71M Completed Startup
1. Spin-Off 25-Jun-2025 Completed Startup
To view Hawkhill Therapeutics’s complete valuation and funding history, request access »

Hawkhill Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Seed 3
Series Seed 1
To view Hawkhill Therapeutics’s complete cap table history, request access »

Hawkhill Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hawkhill Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Epidarex Capital Venture Capital Minority
LifeLink Ventures Venture Capital Minority
Novo Nordisk Corporation Minority
o2h Holding Company Minority
Angel (individual) Minority
You’re viewing 5 of 6 investors. Get the full list »

Hawkhill Therapeutics FAQs

  • When was Hawkhill Therapeutics founded?

    Hawkhill Therapeutics was founded in 2025.

  • Where is Hawkhill Therapeutics headquartered?

    Hawkhill Therapeutics is headquartered in Dundee, United Kingdom.

  • What is the size of Hawkhill Therapeutics?

    Hawkhill Therapeutics has 9 total employees.

  • What industry is Hawkhill Therapeutics in?

    Hawkhill Therapeutics’s primary industry is Biotechnology.

  • Is Hawkhill Therapeutics a private or public company?

    Hawkhill Therapeutics is a Private company.

  • What is the current valuation of Hawkhill Therapeutics?

    The current valuation of Hawkhill Therapeutics is .

  • What is Hawkhill Therapeutics’s current revenue?

    The current revenue for Hawkhill Therapeutics is .

  • How much funding has Hawkhill Therapeutics raised over time?

    Hawkhill Therapeutics has raised $3.71M.

  • Who are Hawkhill Therapeutics’s investors?

    Epidarex Capital, LifeLink Ventures, Novo Nordisk, o2h, and are 5 of 6 investors who have invested in Hawkhill Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process